Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer

Piero Dalerba

doi:10.1016/j.jval.2021.09.006

Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer

Piero Dalerba

Center for Discovery and Innovation

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	382-384
Number of pages	3
Journal	Value in Health
Volume	25
Issue number	3
DOIs	https://doi.org/10.1016/j.jval.2021.09.006
State	Published - Mar 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jval.2021.09.006

Cite this

@article{31b2d36805204391ac1edb6b509d64bf,

title = "Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer",

author = "Piero Dalerba",

year = "2022",

month = mar,

doi = "10.1016/j.jval.2021.09.006",

language = "English",

volume = "25",

pages = "382--384",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd",

number = "3",

}

TY - JOUR

T1 - Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer

AU - Dalerba, Piero

PY - 2022/3

Y1 - 2022/3

UR - https://www.scopus.com/pages/publications/85119481026

U2 - 10.1016/j.jval.2021.09.006

DO - 10.1016/j.jval.2021.09.006

M3 - Editorial

C2 - 35227449

AN - SCOPUS:85119481026

SN - 1098-3015

VL - 25

SP - 382

EP - 384

JO - Value in Health

JF - Value in Health

IS - 3

ER -

Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer

UN SDGs

Access to Document

Other files and links

Cite this